MRA Advisory Group Raises Stake in Doximity, Inc. $DOCS

Key Points

• MRA Advisory Group has increased its stake in Doximity, Inc. by 57.9%, owning 13,733 shares valued at approximately $842,000.
• Doximity reported $0.36 EPS for the last quarter, exceeding analysts' expectations, with a net margin of 36.60% and revenue growth of 15.2% year-over-year.
• Analysts have varying opinions on Doximity, with price targets ranging from $55.00 to $80.00 and an average rating of "Moderate Buy."

MRA Advisory Group increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 57.9% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 13,733 shares of the company's stock after purchasing an additional 5,038 shares during the period. MRA Advisory Group's holdings in Doximity were worth $842,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Ballentine Partners LLC purchased a new stake in Doximity during the 1st quarter worth about $201,000. Wealth Enhancement Advisory Services LLC lifted its holdings in Doximity by 196.6% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 13,570 shares of the company's stock worth $787,000 after purchasing an additional 8,995 shares in the last quarter. Range Financial Group LLC purchased a new stake in Doximity during the 1st quarter worth about $916,000. Bank of Nova Scotia purchased a new stake in shares of Doximity in the 1st quarter valued at about $651,000. Finally, New York State Teachers Retirement System raised its holdings in shares of Doximity by 10.9% in the 1st quarter. New York State Teachers Retirement System now owns 113,145 shares of the company's stock valued at $6,566,000 after acquiring an additional 11,078 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Price Performance

Shares of Doximity stock opened at $71.05 on Monday. The business's 50 day simple moving average is $63.60 and its two-hundred day simple moving average is $59.77. The stock has a market capitalization of $13.31 billion, a P/E ratio of 71.05, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a one year low of $38.30 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's revenue was up 15.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Sell-side analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the transaction, the director directly owned 6,360 shares of the company's stock, valued at approximately $381,600. The trade was a 61.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Regina M. Benjamin sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at $997,080. This trade represents a 37.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,000 shares of company stock valued at $1,929,380. Company insiders own 31.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on DOCS shares. Piper Sandler raised their price target on Doximity from $65.00 to $69.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Bank of America raised their price target on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. JPMorgan Chase & Co. lowered their price target on Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday, May 27th. Robert W. Baird raised their price target on Doximity from $75.00 to $80.00 and gave the company an "outperform" rating in a report on Thursday. Finally, KeyCorp raised their price target on Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $67.00.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.